FR2750704B1 - Procede de production d'adn therapeutique - Google Patents

Procede de production d'adn therapeutique

Info

Publication number
FR2750704B1
FR2750704B1 FR9608327A FR9608327A FR2750704B1 FR 2750704 B1 FR2750704 B1 FR 2750704B1 FR 9608327 A FR9608327 A FR 9608327A FR 9608327 A FR9608327 A FR 9608327A FR 2750704 B1 FR2750704 B1 FR 2750704B1
Authority
FR
France
Prior art keywords
therapeutic dna
producing therapeutic
producing
dna
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9608327A
Other languages
English (en)
Other versions
FR2750704A1 (fr
Inventor
Beatrice Cameron
Joel Crouzet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9608327A priority Critical patent/FR2750704B1/fr
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to JP10504844A priority patent/JP2000514293A/ja
Priority to SK1814-98A priority patent/SK181498A3/sk
Priority to AU34475/97A priority patent/AU722909B2/en
Priority to PCT/FR1997/001116 priority patent/WO1998001540A1/fr
Priority to CZ984382A priority patent/CZ438298A3/cs
Priority to BR9710173A priority patent/BR9710173A/pt
Priority to IL12762097A priority patent/IL127620A0/xx
Priority to EP97930569A priority patent/EP0914418A1/fr
Priority to KR1019980710929A priority patent/KR20000022488A/ko
Priority to US09/202,314 priority patent/US6410273B1/en
Priority to CA002258792A priority patent/CA2258792A1/fr
Priority to ZA9705959A priority patent/ZA975959B/xx
Publication of FR2750704A1 publication Critical patent/FR2750704A1/fr
Application granted granted Critical
Publication of FR2750704B1 publication Critical patent/FR2750704B1/fr
Priority to NO986177A priority patent/NO986177L/no
Priority to US10/037,488 priority patent/US20020187527A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
FR9608327A 1996-07-04 1996-07-04 Procede de production d'adn therapeutique Expired - Fee Related FR2750704B1 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FR9608327A FR2750704B1 (fr) 1996-07-04 1996-07-04 Procede de production d'adn therapeutique
US09/202,314 US6410273B1 (en) 1996-07-04 1997-06-24 Method for producing methylated DNA
AU34475/97A AU722909B2 (en) 1996-07-04 1997-06-24 Method for the production of a therapeutic DNA
PCT/FR1997/001116 WO1998001540A1 (fr) 1996-07-04 1997-06-24 Procede de production d'adn therapeutique
CZ984382A CZ438298A3 (cs) 1996-07-04 1997-06-24 Způsob přípravy DNA pro použití v genové terapii
BR9710173A BR9710173A (pt) 1996-07-04 1997-06-24 Processo de preparação de dna utilizável em terapia gênica utilização de um dna plasmático para a preparaç~o de uma composição farmacêutica destinada ao tratamento terapêutico ou ao diagnóstico do corpo humano ou animal processo de preparação desta composição farmacêutica e composição compreendendo um dna bacteriano
IL12762097A IL127620A0 (en) 1996-07-04 1997-06-24 Method for producing therapeutic DNA
EP97930569A EP0914418A1 (fr) 1996-07-04 1997-06-24 Procede de production d'adn therapeutique
JP10504844A JP2000514293A (ja) 1996-07-04 1997-06-24 治療用ｄｎａの作製方法
SK1814-98A SK181498A3 (en) 1996-07-04 1997-06-24 Method for producing therapeutic dna, application of plasmid dna for producing a pharmaceutical composition
CA002258792A CA2258792A1 (fr) 1996-07-04 1997-06-24 Procede de production d'adn therapeutique
KR1019980710929A KR20000022488A (ko) 1996-07-04 1997-06-24 치료 디엔에이 생성방법
ZA9705959A ZA975959B (en) 1996-07-04 1997-07-03 Method for the production of a therapeutic DNA.
NO986177A NO986177L (no) 1996-07-04 1998-12-29 FremgangsmÕte for fremstilling av terapeutisk DNA
US10/037,488 US20020187527A1 (en) 1996-07-04 2001-12-28 Method for producing therapeutic DNA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9608327A FR2750704B1 (fr) 1996-07-04 1996-07-04 Procede de production d'adn therapeutique

Publications (2)

Publication Number Publication Date
FR2750704A1 FR2750704A1 (fr) 1998-01-09
FR2750704B1 true FR2750704B1 (fr) 1998-09-25

Family

ID=9493705

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9608327A Expired - Fee Related FR2750704B1 (fr) 1996-07-04 1996-07-04 Procede de production d'adn therapeutique

Country Status (14)

Country Link
US (2) US6410273B1 (fr)
EP (1) EP0914418A1 (fr)
JP (1) JP2000514293A (fr)
KR (1) KR20000022488A (fr)
AU (1) AU722909B2 (fr)
BR (1) BR9710173A (fr)
CA (1) CA2258792A1 (fr)
CZ (1) CZ438298A3 (fr)
FR (1) FR2750704B1 (fr)
IL (1) IL127620A0 (fr)
NO (1) NO986177L (fr)
SK (1) SK181498A3 (fr)
WO (1) WO1998001540A1 (fr)
ZA (1) ZA975959B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026468B2 (en) 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
US7026155B2 (en) * 1999-02-02 2006-04-11 Regents Of The University Of California Method of reducing bacterial proliferation
US6667174B2 (en) * 2000-09-18 2003-12-23 Genzyme Corporation Expression vectors containing hybrid ubiquitin promoters
GB0025913D0 (en) * 2000-10-23 2000-12-06 Guldberg Per Materials and methods relating to nucleic acid amplification and profiling
US20030152950A1 (en) * 2001-06-27 2003-08-14 Garner Harold R. Identification of chemically modified polymers
US20060270043A1 (en) * 2002-01-23 2006-11-30 Blattner Frederick R Bacteria with reduced genome
US6989265B2 (en) * 2002-01-23 2006-01-24 Wisconsin Alumni Research Foundation Bacteria with reduced genome
US8119365B2 (en) * 2002-01-23 2012-02-21 Wisconsin Alumni Research Foundation Insertion sequence-free bacteria
US8765408B2 (en) 2002-01-23 2014-07-01 Wisconsin Alumni Research Foundation Prophage element-free bacteria
US8039243B2 (en) * 2002-01-23 2011-10-18 Wisconsin Alumni Research Foundation Insertion sequence-free bacteria
US7303906B2 (en) 2002-09-06 2007-12-04 Wisconsin Alumni Research Foundation Competent bacteria
US20090191218A1 (en) * 2005-05-11 2009-07-30 Fengchun Li DNA Vaccines And Methods For The Prevention Of Transplantation Rejection
AU2006247857B2 (en) * 2005-05-11 2009-10-22 Loma Linda University Substances, compositions and methods for preventing and treating immune-mediated inflammatory disorders
EP2868743B1 (fr) * 2006-09-28 2017-11-15 Loma Linda University Transfection médiée par des cellules apoptotiques de cellules de mammifère au moyen d'ARN interférant
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
US11680273B2 (en) 2011-09-23 2023-06-20 Loma Linda University Treatment of autoimmune diseases
EP2758074B1 (fr) 2011-09-23 2020-04-22 Loma Linda University Souches bactériennes exprimant des gènes de méthylase et leurs utilisations
EP3921416A1 (fr) * 2019-02-06 2021-12-15 Fred Hutchinson Cancer Research Center Bactéries productrices de minicercle conçues pour produire de manière différentielle des molécules d'acide nucléique à l'intérieur de celles-ci

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5491060A (en) * 1989-05-01 1996-02-13 The University Of Maryland Mutant strain of E. coli for detection of methyltransferase clones
EP0412676B1 (fr) * 1989-08-07 1995-06-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Procédé de production de la DNA méthylase de spiroplasma sp.
US5405760A (en) * 1992-04-30 1995-04-11 New England Biolabs, Inc. Process for producing recombinant McrBC endonuclease and cleavage of methylated DNA
US5470740A (en) * 1993-11-04 1995-11-28 Life Technologies, Inc. Cloned NsiI restriction-modification system
US5587305A (en) * 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
FR2714830B1 (fr) 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
WO1996002555A1 (fr) * 1994-07-15 1996-02-01 The University Of Iowa Research Foundation Oligonucleotides immunomodulateurs
FR2730637B1 (fr) 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
FR2739292B1 (fr) 1995-09-28 1997-10-31 Rhone Poulenc Rorer Sa Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations
FR2741066B1 (fr) 1995-11-14 1997-12-12 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
FR2754272B1 (fr) 1996-10-08 1998-11-13 Rhone Poulenc Rorer Sa Procede de preparation de compositions pour le transfert d'acides nucleiques
US6060245A (en) 1996-12-13 2000-05-09 Stratagene Methods and adaptors for generating specific nucleic acid populations

Also Published As

Publication number Publication date
AU3447597A (en) 1998-02-02
NO986177D0 (no) 1998-12-29
CA2258792A1 (fr) 1998-01-15
BR9710173A (pt) 1999-08-10
CZ438298A3 (cs) 1999-04-14
IL127620A0 (en) 1999-10-28
JP2000514293A (ja) 2000-10-31
FR2750704A1 (fr) 1998-01-09
US20020187527A1 (en) 2002-12-12
SK181498A3 (en) 1999-07-12
NO986177L (no) 1999-02-15
EP0914418A1 (fr) 1999-05-12
US6410273B1 (en) 2002-06-25
WO1998001540A1 (fr) 1998-01-15
AU722909B2 (en) 2000-08-17
ZA975959B (en) 1998-01-30
KR20000022488A (ko) 2000-04-25

Similar Documents

Publication Publication Date Title
FR2750704B1 (fr) Procede de production d'adn therapeutique
HUP9602685A3 (en) Substituted quinoline-2-carboxylic-amides, process for producing them, their use as medicines and intermediates
MA22911A1 (fr) Procede de production de formulations de vaccins.
DZ1880A1 (fr) Forme posologique d'azithromycine et son procédé de production.
BR9612297A (pt) Método de produção de 1,1,1,3,3-pentafluorpropano
FR2749778B1 (fr) Procede de preparation de catalyseurs d'hydrotraitement
FR2764211B1 (fr) Procede de preparation de catalyseurs d'hydrotraitement
FR2761977B1 (fr) Procede d'enrichissement de sel brut
FR2753204B1 (fr) Procede de preparation d'adn plasmidique
FR2687687B1 (fr) Procede pour mesurer la taille de fragments d'adn.
EP0758679A4 (fr) Procede de production d'acide 2-ceto-l-gulonique
FR2771089B1 (fr) Procede de production d'acide acrylique
HUP9801687A3 (en) Process for producing nucleic acids
MA23714A1 (fr) Procede de production de n-phosphonomethylglycine
FR2636738B1 (fr) Procede et installation de sequencage de l'adn
MA22151A1 (fr) Procede de production d'azabenzimidazoles
FR2733227B1 (fr) Procede pour la preparation de 1,1-difluoroethane
FR2739373B1 (fr) Procede de preparation de catalyseurs d'ammoxydation
NO950807D0 (no) Fremgangsmåte for fremstilling av karbonelektroder
FR2663941B1 (fr) Procede de production d'organosiloxanes.
FR2777006B1 (fr) Procede de preparation d'hydrogenosilanes par hydrogenolyse catalytique de polysilanes
ITRM960874A0 (it) Procedimento migliorato per la produzione di 5-idrossimetiltiazolo
FR2696475B1 (fr) Procede de production de micro-algues.
FR2625194B1 (fr) Procede de production d'aldehydes aromatiques
FR2595714B1 (fr) Procede perfectionne de production d'interleukine-0

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse